<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04416412</url>
  </required_header>
  <id_info>
    <org_study_id>D20058</org_study_id>
    <secondary_id>OR190062</secondary_id>
    <nct_id>NCT04416412</nct_id>
  </id_info>
  <brief_title>ICG Fluorescence Imaging in Open Fracture Trauma Patients</brief_title>
  <official_title>Optimizing Surgical Debridement Following High-energy Open Trauma With Dynamic Contrast-enhanced Fluorescence Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dartmouth-Hitchcock Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dartmouth College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>United States Department of Defense</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>Brigham and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, Irvine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Maryland, Baltimore</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Dartmouth-Hitchcock Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective observational study that will evaluate the association between bone and&#xD;
      tissue perfusion, as measured by indocyanine green (ICG) fluorescence imaging, and&#xD;
      complications, in an effort to develop ICG fluorescence imaging as a diagnostic tool to&#xD;
      quantitatively guide operative debridement.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective observational study that will evaluate the association between bone and&#xD;
      tissue perfusion, as measured using indocyanine green (ICG) fluorescence imaging, and&#xD;
      complications. This will be used to develop ICG fluorescence imaging as a diagnostic tool to&#xD;
      objectively and quantitatively guide operative debridement. The study population includes all&#xD;
      open fracture patients regardless of race, ethnicity, or sex/gender. Primary outcome measure&#xD;
      is all-cause re-operation and secondary outcome measure is surgical site infection. All&#xD;
      patients will be followed for a total of 12 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2020</start_date>
  <completion_date type="Anticipated">January 31, 2026</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2025</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Number of participants who undergo an unplanned fracture-related reoperation</measure>
    <time_frame>12 months</time_frame>
    <description>All unplanned reoperations will be documented using a specific case report form</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of participants who experience a post-procedure surgical site infection</measure>
    <time_frame>12 months</time_frame>
    <description>Post-procedure surgical site infection using Centers for Disease Control criteria will be documented at each follow-up</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Trauma Injury</condition>
  <arm_group>
    <arm_group_label>Open Fracture Cohort</arm_group_label>
    <description>Patients 18 years of age or older. Open extremity fracture. Planned definitive fracture management with external fixation, internal fixation, or joint fusion.&#xD;
Open fracture wound management that includes formal surgical debridement within 72 hours of their injury.&#xD;
Will have all planned fracture care surgeries performed by a participating surgeon or delegate.&#xD;
Provision of informed consent.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Immunofluorescence Imaging</intervention_name>
    <description>Patients will be administered FDA approved ICG through intravenous injection and imaged by a FDA approved surgical microscope (Spy Elite) which is 0.5 meter away from the subject. Both ICG fluorescence and the two imaging systems have been used for routine clinical practice for many years. Figure (a) shows the Schematic sketch of the imaging systems. ICG fluorescence imaging utilizes intravenously injected ICG, which is a fluorescent dye that is FDA-approved for clinical use, illuminated with near-infrared light. The ICG dye is indirectly activated and the dynamic fluorescence due to bone perfusion can be captured by a video rate imaging system.</description>
    <arm_group_label>Open Fracture Cohort</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients 18 years of age or older who present with an open fracture will be considered for&#xD;
        the open fracture cohort.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients 18 years of age or older.&#xD;
&#xD;
          2. Open extremity fracture.&#xD;
&#xD;
          3. Planned definitive fracture management with external fixation, internal fixation, or&#xD;
             joint fusion.&#xD;
&#xD;
          4. Open fracture wound management that includes formal surgical debridement within 72&#xD;
             hours of their injury.&#xD;
&#xD;
          5. Will have all planned fracture care surgeries performed by a participating surgeon or&#xD;
             delegate.&#xD;
&#xD;
          6. Provision of informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Inability of patient to provide informed consent&#xD;
&#xD;
          2. Fracture of the hand.&#xD;
&#xD;
          3. Iodine allergy.&#xD;
&#xD;
          4. Received previous surgical debridement or management of their fracture at a&#xD;
             non-participating hospital or clinic.&#xD;
&#xD;
          5. Open fracture managed outside of the participating orthopaedic service.&#xD;
&#xD;
          6. Chronic or acute infection at or near the fracture site at the time of initial&#xD;
             fracture surgery.&#xD;
&#xD;
          7. Burns at the fracture site.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ida L Gitajn, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dartmouth-Hitchcock Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amy Hall, MS</last_name>
    <phone>603-653-3306</phone>
    <email>amy.e.hall@hitchcock.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Melanie L Christian</last_name>
    <phone>6036503556</phone>
    <email>melanie.l.christian@hitchcock.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dartmouth Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ida L Gitajn, MD</last_name>
      <phone>603-650-5000</phone>
      <email>ida.l.gitajn@hitchcock.org</email>
    </contact>
    <contact_backup>
      <last_name>Amy E Hall, MS</last_name>
      <phone>603-653-3306</phone>
      <email>amy.e.hall@hitchcock.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>May 21, 2020</study_first_submitted>
  <study_first_submitted_qc>June 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 4, 2020</study_first_posted>
  <last_update_submitted>September 28, 2021</last_update_submitted>
  <last_update_submitted_qc>September 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dartmouth-Hitchcock Medical Center</investigator_affiliation>
    <investigator_full_name>Ida Leah Gitajn</investigator_full_name>
    <investigator_title>Physician</investigator_title>
  </responsible_party>
  <keyword>Immunofluorescence</keyword>
  <keyword>Orthopaedic</keyword>
  <keyword>Trauma</keyword>
  <keyword>Open Fracture</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

